Modeling the functional effects of allosteric modulators at pharmacological receptors: An extension of the two-state model of receptor activation

Molecular Pharmacology

Volumn 58, Issue 6, 2000, Pages 1412-1423

  Hall, David A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; ADENOSINE A1 RECEPTOR; BENZODIAZEPINE RECEPTOR; DRUG RECEPTOR; GLUTAMATE RECEPTOR;

ALLOSTERISM; DRUG EFFECT; DRUG RECEPTOR BINDING; LIGAND BINDING; MATHEMATICAL MODEL; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033669603     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.6.1412     Document Type: Short Survey

References (29)

1. Operational models of pharmacological agonism
2. 1 receptor binding and function by 2-amino-3-benzoylthiophenes
3. The relation between classical and cooperative models for drug action
4. Co-agonism in drug-receptor interaction: Illustrated by the NMDA receptor
5. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled -adrenergic receptor
6. Estimation of affinities of allosteric ligands using radioligand binding and pharmacological null methods
7. An allosteric model for benzodiazepine receptor function
8. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes
9. The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes
10. 2 dopamine receptors by amiloride and amiloride analogues
11. Functional activity of the adenosine binding enhancer, PD 81, 723, in the in vitro hippocampal slice
12. On the application of 'a plausible model' of allosteric proteins to the receptor for acetylcholine
13. Allosteric enhancer PD 81, 723 acts by novel mechanism to potentiate cardiac actions of adenosine
14. 1 receptor
15. Detection, quantification and verification of allosteric interactions of agents with labelled and unlabelled ligands at G-protein coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors
16. Sub-type selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: Radioligand binding studies
17. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes
18. The two-state model of receptor activation
19. Characterisation of the allosteric interactions between antagonists and amiloride analogues at the human α(2A)-adrenergic receptor
20. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signalling without affecting glutamate binding
21. Competition between positive and negative allosteric effectors on muscarinic receptors
22. A modification of receptor theory
23. Modification of the binding properties of muscarinic receptors by gallamine
24. On the analysis of pharmacological experiments in terms of an allosteric model
25. Allosteric modulation of muscarinic acetylcholine receptors
26. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors
27. The cubic ternary complex receptor-occupancy model I. Model description
28. The cubic ternary complex receptor-occupancy model II. Understanding apparent affinity
29. The cubic ternary complex receptor-occupancy model III. Resurrecting efficacy